2.
Elsevier ClinicalKey Clinical Overview
Treatment
Patient has concurrent purulent conjunctivitis
Patient has history of recurrent acute otitis media unresponsive to amoxicillin
Patient for whom amoxicillin has failed at 48 to 72 hours
Some experts suggest amoxicillin-clavulanate could be the preferred treatment for all children owing to the increase in cases caused by Haemophilus influenzae and decrease in prevalence of penicillin-resistant Streptococcus pneumoniae
However, treatment failure and recurrence remain uncommon, and rates are lower for amoxicillin than for other agents despite changes in acute otitis media etiology
Patients with penicillin allergy
Cephalosporin cross-reaction rates are low (0.1%) among patients with a history of mild to moderate penicillin allergy (not severe reactions)
The following antibiotics are recommended as first line therapy for patients without severe and/or recent penicillin allergy when skin testing is not available:
Cefdinir
Cefuroxime
Cefpodoxime
Ceftriaxone
If patient's condition fails to improve or respond to initial therapy after 48 to 72 hours, change initial antibiotic to either of the following
Amoxicillin-clavulanate combination
Ceftriaxone (3-day course)
Alternative second line therapies after 48 to 72 hours of initial antibiotic treatment
Cefpodoxime or cefdinir (third-generation cephalosporins) plus clindamycin
Ceftriaxone (3-day course) plus clindamycin
Second- or third-generation cephalosporin treatment alone is also recommended by some experts
When treatment persistently fails, consult otolaryngology subspecialist for further antibiotic therapy recommendations, follow-up, and possible tympanocentesis
Macrolides have limited efficacy against Haemophilus influenzae and many Streptococcus pneumoniae middle ear isolates
Treatment
Amoxicillin Trihydrate, Clavulanate Potassium Oral suspension; Children 6 to 12 years: 90 mg/kg/day amoxicillin component (Max: 4,000 mg amoxicillin/day) PO divided every 12 hours for 5 to 7 days for mild to moderate disease and 10 days for severe disease.
If child has a penicillin allergy, alternative first line oral therapies include:
Cefdinir
Cefdinir Oral suspension; Infants 2 to 5 months†: 7 mg/kg/dose PO every 12 hours or 14 mg/kg/dose PO every 24 hours for 10 days.
Cefdinir Oral suspension; Infants and Children 6 to 23 months: 7 mg/kg/dose (Max: 300 mg/dose) PO every 12 hours or 14 mg/kg/dose (Max: 600 mg/dose) PO every 24 hours for 10 days.
Cefdinir Oral suspension; Children 2 to 5 years: 7 mg/kg/dose (Max: 300 mg/dose) PO every 12 hours or 14 mg/kg/dose (Max: 600 mg/dose) PO every 24 hours for 7 days for mild to moderate disease and 10 days for severe disease.
Cefdinir Oral suspension; Children 6 years and older: 7 mg/kg/dose (Max: 300 mg/dose) PO every 12 hours or 14 mg/kg/dose (Max: 600 mg/dose) PO every 24 hours for 5 to 7 days for mild to moderate disease and 10 days for severe disease.
Cefuroxime
Cefuroxime Axetil Oral suspension; Infants and Children 3 to 23 months: 15 mg/kg/dose PO every 12 hours for 10 days.
Cefuroxime Axetil Oral suspension; Children 2 to 5 years: 15 mg/kg/dose PO every 12 hours for 7 days for mild to moderate disease and 10 days for severe disease.